ArticleTranslational andrology and urology2026
Pediatric non-rhabdomyosarcoma bladder tumors (NRBTs): a 20-year retrospective longitudinal cohort study at a tertiary referral center.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric non-rhabdomyosarcoma bladder tumors (NRBTs) encompass a diverse spectrum of tumors with low incidence rates. This study aims to improve understanding and contribute to the management of pediatric NRBTs. Methods: We retrospectively enrolled patients with primary pediatric NRBTs diagnosed and treated at our center between 2003 and 2023. Clinicodemographic and clinicopathological data were collected. NRBTs were classified into four categories: urothelial tumors (UTs), mesenchymal tumors (MTs), neuroendocrine tumors (NTs), and rare types of bladder tumors (rBTs). Intergroup comparative analyses were conducted. Results: We identified 51 cases of NRBTs. Four categories encompassed: UTs (n=25, 49.0%), MTs (n=17, 33.3%) and NTs (n=5, 9.8%), and rBTs (n=4, 7.8%). No cases of UTs were identified below the age of 3 years. Comparative analyses demonstrated significant intergroup differences in preoperative anemia prevalence (P=0.02) and tumor size (P<0.001). Total 45 patients (88.2%) completed follow-up, with a median duration of 64 months [interquartile range (IQR), 28-113 months]. Local recurrences were identified in 5 cases (11.1%), among whom 1 case (2.0%) succumbed to local recurrence and disease progression. Conclusions: Pediatric NRBTs demonstrate generally favorable clinical outcomes. Age under 3 years, preoperative anemia or a maximum tumor diameter exceeding 3 cm should raise a strong suspicion for non-UTs bladder tumors. Postoperative surveillance protocols can incorporate urinary ultrasonography (US) as a non-invasive monitoring tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.